LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,454 | 31,719 | 16,035 | 4,373 | 5,169 |
| Marketable Securities | 8,615 | 9,021 | 9,327 | 34,986 | 44,902 |
| TOTAL | $27,054 | $42,230 | $26,332 | $40,377 | $51,024 |
| Non-Current Assets | |||||
| PPE Net | 1,118 | 1,268 | 1,082 | 1,271 | 1,304 |
| Intangibles | 2,579 | 2,710 | 2,770 | 2,757 | 3,033 |
| TOTAL | $3,697 | $3,978 | $3,852 | $4,028 | $4,337 |
| Total Assets | $30,751 | $46,208 | $30,184 | $44,405 | $55,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,933 | 2,184 | 3,078 | 2,203 | 1,866 |
| Accrued Expenses | 6,935 | 8,090 | 5,557 | 8,145 | 6,459 |
| TOTAL | $11,027 | $10,427 | $8,780 | $10,496 | $8,420 |
| Non-Current Liabilities | |||||
| Long Term Debt | 222 | 263 | 304 | 344 | 186 |
| TOTAL | $259 | $303 | $346 | $388 | $186 |
| Total Liabilities | $11,286 | $10,730 | $9,126 | $10,884 | $8,606 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,422 | 55,326 | 39,671 | 39,631 | 39,607 |
| Common Shares | 554 | 553 | 397 | 396 | 396 |
| Retained earnings | -398,539 | -381,405 | -366,470 | -352,833 | -338,433 |
| Other shareholders' equity | 1 | 0 | 0 | 14 | 17 |
| TOTAL | $19,465 | $35,478 | $21,058 | $33,521 | $46,755 |
| Total Liabilities And Equity | $30,751 | $46,208 | $30,184 | $44,405 | $55,361 |